First reported case of unrepaired tetralogy of Fallot complicated with coronavirus disease-19 (COVID-19)

The incidence of novel coronavirus disease-19 (nCoV-19) and its associated complications is higher in high-risk groups. In this article, we explain the symptoms and course of the disease and the treatment for an adult patient with CHD who has been infected with novel nCoV-19.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cardiology in the young 2020-09, Vol.30 (9), p.1339-1342
Hauptverfasser:	Moazenzadeh, Mansoor, Jafari, Fatemeh, Farrokhnia, Mehrdad, Aliramezany, Maryam
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin-Converting Enzyme Inhibitors - administration & dosage Betacoronavirus - isolation & purification Brief Report Cardiomegaly - diagnosis Cardiomegaly - etiology Cardiovascular disease Comorbidity Complications Congenital diseases Consent Coronavirus Infections - diagnosis Coronavirus Infections - physiopathology Coronavirus Infections - therapy Coronaviruses COVID-19 Cyanosis Cyanosis - diagnosis Cyanosis - etiology Diagnosis, Differential Diuretics - administration & dosage Dyspnea Echocardiography - methods Electrocardiography - methods Humans Hypoxia Infections Infectious diseases Laboratories Lung - diagnostic imaging Male Medical imaging Middle Aged Oximetry - methods Oxygen Inhalation Therapy - methods Oxygen saturation Pandemics Patients Phlebotomy Pneumonia Pneumonia, Viral - diagnosis Pneumonia, Viral - physiopathology Pneumonia, Viral - therapy Pulmonary arteries Risk groups SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Signs and symptoms Tetralogy of Fallot Tetralogy of Fallot - diagnosis Tetralogy of Fallot - physiopathology Tetralogy of Fallot - therapy Tomography, X-Ray Computed - methods Treatment Outcome Veins & arteries Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The incidence of novel coronavirus disease-19 (nCoV-19) and its associated complications is higher in high-risk groups. In this article, we explain the symptoms and course of the disease and the treatment for an adult patient with CHD who has been infected with novel nCoV-19.
ISSN:	1047-9511 1467-1107
DOI:	10.1017/S1047951120001821